Dr. Oliver Viera-Segura obtained a bachelor´s degree in Biopharmaceutical Chemistry from the Universidad Autonoma de Nayarit in Nayarit, Mexico. As a bachelor, he was employed as a head lab at the tertiary hospital focused on new drug clinical trials. He finished a Ph.D. in Molecular Biology in Medicine in 2020, evaluating the molecular epidemiology of hepatitis E virus and the cytokines associated with the infection in patients with impaired liver function as dissertations work. During the SARS-CoV-2 pandemic, he worked on the viral diagnosis as a support for the local community. The current lines of investigations are related to the description of hepatic and respiratory viral molecular epidemiology and in vitro studies for anti-viral drugs.